Company Overview and News
U.S. Silica Holdings, Inc. (SLCA - Free Report) is a seller of commercial silica in the United States.The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 30 days.
ATU WBC WBC EMES WEBNF WBK SLCA
Document Table of Contents
2018-08-01 zacks - 1
An Earnings Miss: Fracking sand player Emerge Energy Services L.P. (EMES - Free Report) reported earnings per unit of 30 cents, lower than the Zacks Consensus Estimate 38 cents.
Barclays (BCS - Free Report) is slated to announce second-quarter 2018 results on Aug 2, before the opening bell. For the to-be-reported quarter, it is expected to record year-over-year growth in revenues as well as earnings. Lower expenses, rise in trading income and decline in credit impairment charges supported the company’s results in the last reported quarter. However, fall in interest income and muted underwriting fees acted as headwinds.
CWH AMKR TNTTF TD HCS HSB RBS 0005 HSEA HSEB EMES TD RBS HSBC HBCYF
Facebook, Inc. (FB - Free Report) and Netflix, Inc. (NFLX - Free Report) are bleeding after reporting disappointing second-quarter results and it’s taking a toll on other tech stocks. FAANG stocks, which comprise Facebook, Amazon.com, Inc (AMZN - Free Report) , Apple, Inc (AAPL - Free Report) , Netflix and Google parent Alphabet, Inc. (GOOGL - Free Report) , are at the helm of carnage, with the Nasdaq falling 1.
CWH FB AMKR AMZN GOOGL AAPL EMES NFLX
Office Depot, Inc. (ODP - Free Report) , which is slated to release second-quarter 2018 results on Aug 7, has witnessed its shares rise 7.3% in the past three months, marginally outperforming the industry’s growth of 6.9%. The question lingering in investors’ minds is whether this supplier of a range of office products and services will be able to post positive earnings surprise in the quarter to be reported.
CWH AMKR DSW ODP EMES FL URBN
We are in the thick of second-quarter earnings season, which is showing overall growth. Per the latest Earnings Preview, 265 S&P 500 companies (collectively accounting for 66.2% of the index’s total market capitalization) have already reported quarterly results.
CWH LFUS AMKR GNRC GRMN EMES
Several Auto companies, including some big players, have already released their earnings in the past week. In the last couple of days, BorgWarner Inc. (BWA - Free Report) and The Goodyear Tire & Rubber Company (GT - Free Report) reported an earnings beat for the second quarter. A few important companies, which are slated to announce their quarterly numbers on Aug 1, are Tesla, Inc. (TSLA - Free Report) , Ferrari N.
FOXF CWH AMKR BWA MTOR EMES
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to EMES / Emerge Energy Services LP on message board site Silicon Investor.
|THEM (THEMESCAPES.INC.) INTERNET E-COMMERCE||THEM (THEMESCAPES.INC.) INTERNET E-COMMERCE||THEM (THEMESCAPES.INC.) INTERNET E-COMMERCE||Bioanalytical Systemes (BASI)||Bioanalytical Systemes (BASI)||Bioanalytical Systemes (BASI)|
as of ET